CereVasc, Inc. announced that the FDA approved an investigational device exemption application to evaluate the company’s ...

An observational study evaluating operator radiation exposure during endovascular procedures with the Rampart Guardian ...

Medtronic announced that the SPYRAL AFFIRM postapproval study of its Symplicity Spyral renal denervation (RDN) system met its ...

Imperative Care announced new findings from a prespecified sex-specific analysis of the SYMPHONY-PE investigational device ...

IceCure Medical Ltd., developer of minimally invasive cryoablation technology, announced the enrollment of the first two ...

AdvaMed, the Advanced Medical Technical Association, announced it recommended refinements to the Centers for Medicare & Med ...

The United Kingdom’s Medicines and Healthcare Agency (MHRA) announced that the government confirmed it will continue to a ...

Concept Medical announced the presentation of 3-year results from the randomized SIRONA trial of patients with femoropopliteal ...

Jupiter Endovascular, Inc., announced findings from post hoc analyses of its SPIRARE II pivotal trial examining pulmonary ...

Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced that the FDA has approved an ...

The PERT Consortium announced the appointment of Mark McIldiff as Executive Director. As Executive Director, McIldiff will d ...

Rampart announced the launch of Vanguard, a radiation protection solution designed for interventional imagers working at the ...